Financial Trends -- 9/10
NVIDIA delivered extraordinary financial performance in CY2025: $215.9B in revenue (+66% YoY),
$96.6B in free cash flow, and re-accelerating revenue growth at massive scale. Margins compressed
temporarily from the H20 write-down and Blackwell ramp but have recovered to 75% GAAP GM.
Weight: 25%
FY2025 Revenue
$215.9B
CY2025, +66% YoY
Q4 CY2025 Revenue
$68.1B
+73% YoY, re-accelerating
CY2025 FCF
$96.6B
45% of revenue
GAAP Gross Margin
75.0%
Q4 CY2025, recovered from 60.5% trough
Revenue (quarterly)
Key trends
- Revenue grew from $13.5B (Q2 CY2024) to $68.1B (Q4 CY2025) -- a 5x increase in 11 quarters
- YoY growth peaked at +265% in Q4 CY2024, then decelerated through Q2 CY2026 (+56%)
- Growth re-accelerated to +73% in Q4 CY2025, driven by the Blackwell Ultra ramp -- a meaningful inflection at $68B quarterly scale
- Full-year CY2025 revenue of $215.9B vs CY2024 $130.5B (+66% YoY)
- Data Center segment represented 91.5% of Q4 CY2025 revenue ($62.3B)
Source: Daloopa. All figures linked to source records.
GAAP Gross Margin (quarterly)
Key trends
- GAAP GM peaked at 78.4% in Q1 CY2025 before declining -- driven by Blackwell ramp costs and product mix shifts
- Q1 CY2026 saw a sharp drop to 60.5% due to a $4.5B H20 inventory write-down from China export controls; excluding that charge, underlying margins were in the low 70s
- Margins have since recovered sequentially: 72.4% -> 73.4% -> 75.0% through Q4 CY2025
- Q4 CY2025 margin is now expanding YoY again (+200bps), signaling the trough is behind
Source: Daloopa
Operating Income and Margin (quarterly)
Key trends
- Operating income grew from $13.6B (Q4 CY2024) to $44.3B (Q4 CY2025) -- a 3.3x increase
- Operating margin dipped to 49.1% in Q1 CY2026 due to the H20 write-down, then recovered to 65.0% in Q4 CY2025, exceeding prior peaks
- CY2025 full-year operating income of $130.4B with a 60.4% operating margin
- The margin trajectory mirrors gross margin: temporary H20 disruption followed by strong recovery
Source: Daloopa
Free Cash Flow (quarterly)
Key trends
- FCF accelerated from $6.0B (Q2 CY2024) to $34.9B (Q4 CY2025) -- nearly 6x in 11 quarters
- Full-year CY2025 FCF of $96.6B represents 45% of revenue -- extraordinary cash generation
- FCF growth decelerated from +545% (Q2 CY2024) to +38% (Q4 CY2025) as the base effect normalizes, but absolute dollars continue to expand
- CY2025 FCF of $96.6B vs CY2024 $60.7B vs CY2023 $26.9B -- consistent year-over-year expansion
Source: Daloopa
GAAP Diluted EPS (quarterly)
Key trends
- 10:1 stock split occurred in June 2024; pre-split quarters (Q2-Q4 CY2024, Q1-Q2 CY2025) show higher per-share values
- Post-split EPS grew from $0.76 (Q1 CY2026) to $1.76 (Q4 CY2025) -- 132% sequential growth over 4 quarters
- Full-year CY2025 GAAP EPS of $4.90
- Share count modestly declined from ~24.85B to ~24.43B diluted shares, reflecting buybacks partially offsetting SBC dilution
Source: Daloopa
5-Year Annual Series
Key trends
- Revenue compounded from $26.9B (CY2021) to $215.9B (CY2025) -- an 8x increase in 4 years, driven entirely by data center AI demand
- Operating income went from $10.0B to $130.4B over the same period; margins expanded from 37.3% to 60.4%, with a CY2022 trough at 15.7% during the crypto/gaming inventory correction
- FCF grew from $8.0B (CY2021) to $96.6B (CY2025) -- a 12x increase
- Non-GAAP GM peaked at 75.5% in CY2024 and moderated to 71.3% in CY2025 due to Blackwell ramp costs and the H20 write-down
Source: Daloopa
Street Consensus Estimates
| Metric | FY2027E (CY2026E) | FY2028E (CY2027E) |
|---|---|---|
| Revenue | ~$313B | ~$420B+ |
| EPS (GAAP) | ~$5.72 | ~$8.30 |
| Avg. Price Target | $266 (38 analysts) | — |
| Consensus Rating | Strong Buy | — |
- FY2027E revenue of ~$313B implies +45% YoY growth from CY2025, consistent with Blackwell Ultra cycle and hyperscaler CapEx ramp (~$600B aggregate in 2026)
- Forward Non-GAAP P/E of ~21x on CY2027 estimates is below the semiconductor median of ~28x
- Average price target of $266 implies ~50% upside from current $177.39
- 38/38 analysts rate NVDA as Buy or Strong Buy -- zero Sell ratings
Score rationale
Revenue growth has re-accelerated to +73% YoY at $68B quarterly scale. Margins compressed temporarily from the H20 write-down and Blackwell ramp costs but have recovered to 75% GAAP GM. FCF of $96.6B annualized is extraordinary. Share count is modestly declining. The only knock is that margins peaked at 78.4% in Q1 CY2024 and are now at 75%, a ~340bps compression reflecting new product ramp and China disruption. Revenue growth re-acceleration at scale offsets the margin moderation. Score: 9/10 (not 10 because margins are net compressing YoY from 2024 peaks, preventing the "expanding 100+bps" criteria).
Data sourced from Daloopa, company filings, and sell-side consensus estimates.